Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Aug 24;15(9):1042.
doi: 10.3390/ph15091042.

The Challenge of Diagnosing and Managing Pulmonary Arterial Hypertension in Systemic Sclerosis with Interstitial Lung Disease

Elisabetta Zanatta  1 , Martina Perazzolo Marra  2 , Giulia Famoso  2 , Elisabetta Balestro  2 , Chiara Giraudo  2 , Fiorella Calabrese  2 , Federico Rea  2 , Andrea Doria  1
Affiliations
Case Reports

The Challenge of Diagnosing and Managing Pulmonary Arterial Hypertension in Systemic Sclerosis with Interstitial Lung Disease

Elisabetta Zanatta et al. Pharmaceuticals (Basel). .

Abstract

Pulmonary hypertension (PH) in patients with Systemic Sclerosis (SSc) may stem from a variety of underlying causes, thus making a correct diagnosis and management difficult. The main challenges lie in the distinction between pulmonary arterial hypertension (PAH, group 1) and PH due to interstitial lung disease (PH-ILD, group 3) in patients with concomitant lung fibrosis — a very common occurrence in SSc. A consensus among experts remains elusive. Some studies have suggested that among SSc patients with PH, those with an ILD extension > 20% at high-resolution computed tomography (HRCT) should be considered as affected by PH-ILD, whereas other Authors have found that a wide proportion of these patients exhibit features of both PAH and group 3 PH-ILD. We report the case of a 46-year-old male SSc patient with a stable and extensive ILD (>20%) who developed a histologically documented pulmonary vasculopathy typical of PAH and received PAH-specific treatment as bridge to transplant. Moreover, we documented PH disease course by right heart catheterization (RHC), with and without specific vasodilator therapies, which are essential in PAH but not indicated and/or harmful in PH-ILD.

Keywords: interstitial lung disease; pulmonary arterial hypertension; systemic sclerosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Axial High-Resolution Computed Tomography (HRCT) images showing a typical Usual Interstitial Pneumoniae (UIP) pattern that consists of predominantly basal and peripheral reticular opacities and honeycombing with traction bronchiectasis.
Figure 2
Figure 2
Dilated pulmonary artery trunk at repeated HRCT.
Figure 3
Figure 3
Histologic examination of the explanted lungs. Typical usual interstitial pneumonia pattern (UIP) underlying autoimmune disease with peribronchial metaplasia, interstitial fibrosis, nodular lymphocytic infiltration, and micro-honeycombing. Vascular remodelling throughout the lung parenchyma (stars on vessels) (A), haematoxylin and eosin stain (×20). Large/mid-sized arteries with diffuse aspects of medio-intimal hyperplasia (B), haematoxylin and eosin stain (×20). Small vessels showing medial hypertrophy and intimal fibrosis, leading to lumen narrowing (C), haematoxylin and eosin stain (×100). Vascular changes (arrow) were found in more preserved areas as well (D), haematoxylin and eosin stain (×20).
See this image and copyright information in PMC

References

    1. Zanatta E., Polito P., Famoso G., Larosa M., De Zorzi E., Scarpieri E., Cozzi F., Doria A. Pulmonary arterial hypertension in connective tissue disorders: Pathophysiology and treatment. Exp. Biol. Med. 2019;244:120–131. doi: 10.1177/1535370218824101. - DOI - PMC - PubMed
    1. Bruni C., De Luca G., Lazzaroni M.G., Zanatta E., Lepri G., Airò P., Dagna L., Doria A., Matucci-Cerinic M. Screening for pulmonary arterial hypertension in systemic sclerosis: A systematic literature review. Eur. J. Intern. Med. 2020;78:17–25. doi: 10.1016/j.ejim.2020.05.042. - DOI - PubMed
    1. Galiè N., Humbert M., Vachiery J.L., Gibbs S., Lang I., Torbicki A., Simonneau G., Peacock A., Noordegraaf A.V., Beghetti M., et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT) Eur. Respir. J. 2015;46:903–975. - PubMed
    1. Launay D., Montani D., Hassoun P.M., Cottin V., Le Pavec J., Clerson P., Sitbon O., Jaïs X., Savale L., Weatherald J., et al. Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis. PLoS ONE. 2018;13:e0197112. - PMC - PubMed
    1. Young A., Vummidi D., Visovatti S., Homer K., Wilhalme H., White E.S., Flaherty K., McLaughlin V., Khanna D. Prevalence, Treatment, and Outcomes of Coexistent Pulmonary Hypertension and Interstitial Lung Disease in Systemic Sclerosis. Arthritis Rheumatol. 2019;71:1339–1349. doi: 10.1002/art.40862. - DOI - PMC - PubMed

Publication types

LinkOut - more resources